Interdisciplinary Medical Intensive Care, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
Trials. 2023 Jun 10;24(1):390. doi: 10.1186/s13063-023-07418-6.
Increased uptake of sodium is a major cause for cardiovascular disease and mortality. Reduction of daily salt intake below a reference level of 2 g per day (the equivalent to 5 g salt/day) is known to effectively reduce cardiovascular mortality. The widespread use of social media, with a constant increase in video consumption, is opening new avenues for the dissemination of innovative and scalable approaches to health-related information and recommendations for a healthy diet, such as via video interventions with short animated stories (SAS).
This study will evaluate the effect of a sodium intake-SAS video intervention on immediate and medium-term knowledge about dietary sodium. Beyond that, immediate and medium-term effects on behavioral expectation to reduce sodium intake as well as voluntary post-trial engagement with the video content will be examined.
In this 4-armed, parallel, randomized controlled trial, 10,000 adult, US participants will be randomly assigned to (1) a short, animated storytelling intervention video on sodium as a cardiovascular disease risk factor followed by surveys assessing the facts on sodium and cardiovascular disease conveyed in the video (2) the surveys only, (3) an attention placebo control video followed by the before mentioned surveys, and (4) an arm that is exposed to neither the video nor the surveys. Two weeks later, participants in all four arms will complete all of the surveys.
Primary outcomes are the immediate and medium-term effects of the short, animated storytelling intervention video on knowledge about dietary sodium. Secondary outcomes are immediate and medium-term effects of the short, animated storytelling intervention on behavioral expectation to reduce sodium intake as well as voluntary post-trial engagement with the video content.
This study will extend the knowledge on the effects of short, animated storytelling for the containment of the global cardiovascular disease burden. Knowledge on the groups that may be more likely to voluntarily engage with SAS video content will help to improve targeting of future interventions towards audiences at risk. TRIAL REGISTRATION {2A}: ClinicalTrials.gov NCT05735457. Registered on February 21, 2023.
钠摄取量增加是导致心血管疾病和死亡的主要原因。将每日盐摄入量减少到低于 2 克/天(相当于 5 克盐/天)的参考水平,已知可有效降低心血管死亡率。社交媒体的广泛使用,以及视频消费的不断增加,为传播与健康相关的创新和可扩展信息以及健康饮食建议开辟了新途径,例如通过带有简短动画故事的视频干预(SAS)。
本研究将评估钠摄入量-SAS 视频干预对即时和中期饮食钠知识的影响。除此之外,还将研究即时和中期对减少钠摄入量的行为期望以及对视频内容的自愿试用后参与的影响。
在这项 4 臂、平行、随机对照试验中,将有 10000 名美国成年参与者被随机分配到以下 4 组之一:(1)一个关于钠作为心血管疾病风险因素的简短动画讲故事干预视频,然后进行评估视频中传达的钠和心血管疾病相关事实的调查;(2)仅进行调查;(3)一个注意力安慰剂对照视频,然后进行前面提到的调查;(4)既不接触视频也不接触调查的组。两周后,所有 4 组的参与者都将完成所有调查。
主要结果是短期、动画讲故事干预视频对饮食钠知识的即时和中期影响。次要结果是短期、动画讲故事干预对减少钠摄入量的行为期望的即时和中期影响,以及对视频内容的自愿试用后参与。
这项研究将扩展关于短期、动画讲故事的效果的知识,以遏制全球心血管疾病负担。关于可能更愿意自愿参与 SAS 视频内容的人群的知识,将有助于改善针对高危人群的未来干预措施的针对性。试验注册:2A:ClinicalTrials.gov NCT05735457。于 2023 年 2 月 21 日注册。